BELLICUM PHARMACEUTICALS INC (BLCM)

US0794814048 - Common Stock

0.622  -0.07 (-9.72%)

After market: 0.6288 +0.01 (+1.09%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.51M1.50M6.20M500.00K7.14M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
31.20M28.48M30.59M54.58M92.41M
Research and Development
25.49M22.76M23.58M39.05M62.44M
Selling, General, and Administrative Expenses
5.70M5.72M7.01M15.53M29.97M
Operating Income
-29.69M-26.98M-24.39M-54.08M-85.26M
Interest Income/Expense
37.00K46.00K28.00K-2.27M-2.93M
Other Income/Expense
4.17M1.96M15.13M46.13M-22.18M
Non Recurring Items
N/A0.00-478.00K2.50M-2.10M
Income Before Taxes
-25.48M-24.97M-9.71M-7.72M-112.48M
Income Tax
N/A2.00KN/AN/AN/A
Net Income
-25.48M-24.97M-9.71M-7.72M-112.48M
EBITDA
-29.68M-26.97M-24.28M-52.61M-78.08M
 
Per Share Data
EPS Diluted Total Ops
-0.83-0.81-0.84-1.34-24.03
Non GAAP EPS
-0.82-0.81-1.12-7.40-23.92
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-1689.46%-1664.87%-156.53%-1544.00%-1575.35%
Operating Profit Margin
-1968.63%-1798.73%-393.35%-10816.00%-1194.12%

All data in USD

Charts